ABOUT SITUS JUDI MBL77

Not all sufferers with CLL involve therapy. Inspite of all new developments, the iwCLL however suggests watchful observation for sufferers with asymptomatic disease.86 This recommendation is based on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,